A novel mutation in the C3 gene and recurrent invasive pneumococcal infection: a clue for vaccine development.
暂无分享,去创建一个
[1] D. Goldblatt,et al. Circulating pneumococcal specific plasma and memory B cells in the elderly two years after pneumococcal conjugate versus polysaccharide vaccination. , 2010, Vaccine.
[2] M. Roediger,et al. A randomized clinical trial comparing revaccination with pneumococcal conjugate vaccine to polysaccharide vaccine among HIV-infected adults. , 2010, The Journal of infectious diseases.
[3] E. Mulholland,et al. Infants aged 12 months can mount adequate serotype-specific IgG responses to pneumococcal polysaccharide vaccine. , 2010, The Journal of allergy and clinical immunology.
[4] C. Katlama,et al. Cellular CD4 T cell responses to the diphtheria-derived carrier protein of conjugated pneumococcal vaccine and antibody response to pneumococcal vaccination in HIV-infected adults. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] H. Einsele,et al. Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: results from the EBMT IDWP01 trial. , 2010, Vaccine.
[6] C. Whitney,et al. Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 > or = years. , 2010, The Journal of infectious diseases.
[7] M. Lipsitch,et al. The role of complement in innate and adaptive immunity to pneumococcal colonization and sepsis in a murine model. , 2010, Vaccine.
[8] R. Malley. Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development , 2010, Journal of Molecular Medicine.
[9] A. Salar,et al. An Observational Study of Anaemia Management in Patients with NHL Receiving CHOP-14 or -21 (With or Without Rituximab) , 2008 .
[10] D. Gerlier,et al. Human C3 Deficiency Associated with Impairments in Dendritic Cell Differentiation, Memory B Cells, and Regulatory T Cells1 , 2008, The Journal of Immunology.
[11] C. Katlama,et al. Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults , 2007, AIDS.
[12] I. Deary,et al. Complement C3 variant and the risk of age-related macular degeneration. , 2007, The New England journal of medicine.
[13] O. Nadiv,et al. Decreased induction of IL-1beta in fibroblast-like synoviocytes: a possible regulatory mechanism maintaining joint homeostasis. , 2007, Molecular immunology.
[14] A. Caudy,et al. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. , 2006, Journal of the American Society of Nephrology : JASN.
[15] R. Vaughan,et al. Influence of donor C3 allotype on late renal-transplantation outcome. , 2006, The New England journal of medicine.
[16] J. Goodship,et al. Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome. , 2005, Journal of the American Society of Nephrology : JASN.
[17] M. Lipsitch,et al. CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[18] W. Fridman,et al. Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome , 2004, Journal of Medical Genetics.
[19] G. Deschênes,et al. Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases. , 2004, Journal of the American Society of Nephrology : JASN.
[20] M. Nakagawa,et al. Molecular analysis of hereditary deficiency of the third component of complement (C3) in two sisters. , 2001, Internal medicine.
[21] S. Black,et al. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. , 1999, The Pediatric infectious disease journal.
[22] M. Lokki,et al. Inherited complement C3 deficiency: reduced C3 mRNA and protein levels in a Laotian kindred. , 1996, Clinical immunology and immunopathology.
[23] Y. Katz,et al. IL‐13 results in differential regulation of the complement proteins C3 and factor B in tumour necrosis factor (TNF)‐stimulated fibroblasts , 1995, Clinical and experimental immunology.
[24] Z. Fishelson,et al. Inherited human complement C3 deficiency. An amino acid substitution in the beta-chain (ASP549 to ASN) impairs C3 secretion. , 1994, The Journal of biological chemistry.
[25] M. Botto,et al. Homozygous hereditary C3 deficiency due to a partial gene deletion. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[26] M. Daha,et al. An association between homozygous C3 deficiency and low levels of anti‐pneumococcal capsular polysaccharide antibodies , 1992, Clinical and experimental immunology.
[27] M. Botto,et al. Molecular basis of hereditary C3 deficiency. , 1990, The Journal of clinical investigation.
[28] R. Strunk,et al. Synovial fibroblast-like cells synthesize seven proteins of the complement system. , 1988, Arthritis and rheumatism.
[29] E. Reis,et al. Nonsense-codon-mediated decay in human hereditary complement C3 deficiency , 2003, Immunogenetics.
[30] Z. Fishelson,et al. Compound heterozygous complement C3 deficiency. , 1995, Immunology.
[31] D. Houghton,et al. Inherited C3 deficiency with recurrent infections and glomerulonephritis. , 1988, American journal of diseases of children.